Fosfomycin--investigation of a possible new route of administration of an old drug. A case study.
Patients with cystic fibrosis can develop multi-resistant organisms and may have poor intravenous access making antibiotic treatment difficult. This case discusses the successful use of fosfomycin via the subcutaneous route in a paediatric patient with cystic fibrosis.
Cree
Michele
M
Pharmacy Department, Royal Children's Hospital, Brisbane, Australia. Michele_Cree@health.qld.gov.au
Stacey
Sonya
S
Graham
Nicolette
N
Wainwright
Claire
C
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D003550:Cystic Fibrosis / Q000150:complications* / Q000382:microbiology; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D005578:Fosfomycin / Q000008:administration & dosage*; D006801:Humans; D007279:Injections, Subcutaneous; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000209:etiology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000209:etiology
D000900:Anti-Bacterial Agents; D005578:Fosfomycin